封面
市場調查報告書
商品編碼
1212561

調查ELISA(酵素結合免疫吸附檢測法)相關的全球市場

Research ELISA (Enzyme-Linked Immunosorbent Assay)

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 266 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

調查ELISA(酵素結合免疫吸附檢測法)相關的全球市場2030年將達到6億9,230萬美元

在COVID-19後改變的商務環境中,2022年5億1,940萬美元的調查ELISA(酵素結合免疫吸附檢測法)相關的全球市場,在2030年前將達到6億9,230萬美元的規模,在2022年~2030年年複合成長率預計將為3.7%增長。本報告所分析之市場區隔之一的ELISA套件年複合成長率將記錄3.5%,到分析期間結束時達到4億7,860萬美元。考慮疫情後的復甦,ELISA開發套組及抗體一雙領域今後8年的年複合成長率將修正為4.1%。

美國市場估算為1億4,150萬美元,中國則將以年複合成長率6.1%成長預測

關於美國的調查ELISA(酵素結合免疫吸附檢測法)市場在2022年估算為1億4,150萬美元。作為世界第2大經濟大國的中國,在2022年~2030年年複合成長率預計將為6.1%,在2030年將達到1億4,020萬美元的市場規模。其他熱門的地區市場有日本和加拿大,在2022年~2030年預計將各以2%和3.1%的速度成長。在歐洲市場中,德國將以年複合成長率2.5%成長。

調查對像企業範例

  • American Laboratory Products Company(ALPCO)(US)
  • BD Biosciences(US)
  • BioLegend, Inc.(US)
  • Bio-Rad Laboratories, Inc.(US)
  • Enzo Life Sciences, Inc.(US)
  • Merck KGaA
  • Mercodia AB(Sweden)
  • R&D Systems, Inc.(US)
  • Thermo Fischer Scientific Inc.

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東
  • 非洲

第4章 競爭

簡介目錄
Product Code: MCP-6082

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Research ELISA (Enzyme-Linked Immunosorbent Assay) Market to Reach $692.3 Million by 2030

In the changed post COVID-19 business landscape, the global market for Research ELISA (Enzyme-Linked Immunosorbent Assay) estimated at US$519.4 Million in the year 2022, is projected to reach a revised size of US$692.3 Million by 2030, growing at aCAGR of 3.7% over the period 2022-2030. ELISA Kits, one of the segments analyzed in the report, is projected to record 3.5% CAGR and reach US$478.6 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the ELISA Development Sets & Antibody Pairs segment is readjusted to a revised 4.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $141.5 Million, While China is Forecast to Grow at 6.1% CAGR

The Research ELISA (Enzyme-Linked Immunosorbent Assay) market in the U.S. is estimated at US$141.5 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$140.2 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2% and 3.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Select Competitors (Total 27 Featured):

  • American Laboratory Products Company (ALPCO) (US)
  • BD Biosciences (US)
  • BioLegend, Inc. (US)
  • Bio-Rad Laboratories, Inc. (US)
  • Enzo Life Sciences, Inc. (US)
  • Merck KGaA
  • Mercodia AB (Sweden)
  • R&D Systems, Inc. (US)
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • ELISA - A Renowned and Proven Assay Format
    • Recent Market Activity
    • Current and Future Analysis
    • Factors Sustaining Market Growth
    • Factors Restraining Growth
    • ELISA Amid A Challenging Environment
    • Strategies to Counter Competition
    • Technological Advances to Buoy ELISA's Prospects
    • Automation of ELISA - Enabling its Sustenance
    • Growing Popularity of Multiplexing Deters ELISA Market
    • Commoditization: A Key Issue Facing ELISA Product Manufacturers
    • Limited ELISA Application in the Food Industry
    • Available Test Kits at External Laboratories by Allergen
    • Competitive Landscape
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • American Laboratory Products Company (ALPCO) (USA
    • BD Biosciences (USA)
    • BioLegend, Inc. (USA)
    • Bio-Rad Laboratories, Inc. (USA)
    • Enzo Life Sciences, Inc. (USA)
    • Merck KgaA (Germany)
    • Mercodia AB (Sweden)
    • R&D Systems, Inc. (USA)
    • Thermo Fisher Scientific, Inc. (USA)
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 3: World 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for ELISA Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for ELISA Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 6: World 18-Year Perspective for ELISA Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for ELISA Development Sets & Antibody Pairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for ELISA Development Sets & Antibody Pairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 9: World 18-Year Perspective for ELISA Development Sets & Antibody Pairs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 12: World 18-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 15: World 18-Year Perspective for Research Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 16: World Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 19: USA 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 22: USA 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 25: Canada 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 28: Canada 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • JAPAN
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 31: Japan 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 34: Japan 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • CHINA
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 37: China 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 40: China 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • EUROPE
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 43: Europe 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2023 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 46: Europe 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 49: Europe 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • FRANCE
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 52: France 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 55: France 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • GERMANY
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 58: Germany 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 61: Germany 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 64: Italy 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 67: Italy 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • UNITED KINGDOM
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 70: UK 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 73: UK 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 76: Spain 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 79: Spain 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 82: Russia 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 85: Russia 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 88: Rest of Europe 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 91: Rest of Europe 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • ASIA-PACIFIC
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 94: Asia-Pacific 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2023 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 97: Asia-Pacific 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 100: Asia-Pacific 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • AUSTRALIA
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 103: Australia 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 106: Australia 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • INDIA
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 109: India 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 112: India 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 115: South Korea 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 118: South Korea 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • LATIN AMERICA
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 127: Latin America 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2023 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 130: Latin America 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 133: Latin America 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 136: Argentina 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 139: Argentina 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 142: Brazil 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 145: Brazil 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 148: Mexico 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 151: Mexico 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 154: Rest of Latin America 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 157: Rest of Latin America 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • MIDDLE EAST
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 160: Middle East 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2023 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 163: Middle East 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 166: Middle East 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 169: Iran 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 172: Iran 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 175: Israel 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 178: Israel 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 181: Saudi Arabia 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 184: Saudi Arabia 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 187: UAE 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 190: UAE 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 193: Rest of Middle East 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 196: Rest of Middle East 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
  • AFRICA
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 199: Africa 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
    • TABLE 202: Africa 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030

IV. COMPETITION